City
Epaper

Researchers give insight into repairing nerve cells after injury, in chronic disease

By ANI | Updated: November 29, 2023 15:15 IST

La Jolla (California) [US], November 29 : Each year, more than 3 million people in the United States suffer ...

Open in App

La Jolla (California) [US], November 29 : Each year, more than 3 million people in the United States suffer from peripheral neuropathy, a condition in which nerves outside of the brain and spinal cord are destroyed, resulting in pain and loss of feeling in the afflicted areas. Diabetes, injuries, genetically inherited disease, infection, and other factors can all cause peripheral neuropathy.

Salk researchers have discovered a method in mice for mending injured nerves during peripheral neuropathy. They discovered that the protein Mitf aids in the activation of the repair function of specialised Schwann cells in the nervous system.

The findings, which will be published in Cell Reports, have the potential to inspire new therapies that improve repair function and heal peripheral neuropathy.

"We wanted to know what mechanisms control damage response in peripheral nerves under varying conditionslike acute trauma, genetic disorders, or degenerative diseases," says senior author Professor Samuel Pfaff. "We found that Schwann cells, which are special cells in nerves that protect and support neurons' axons, enter their repair state because of a pathway mediated by the protein Mitf."

The peripheral nervous system is made up of all the nerves that branch out from the brain and spinal cord to give us sensation throughout our bodies. There are many cell types in peripheral nerves, but Pfaff and his team focus on understanding neurons, which transmit information throughout the nervous system, and Schwann cells, which protect healthy neurons and repair damaged ones.

The peripheral nervous system's ability to repair damage is remarkable considering that the central nervous systemmade up of the brain and spinal cordis not able to repair damage. Yet, the mechanisms that orchestrate this feat have remained poorly understood.

To unravel how Schwann cells differentiate to begin repairing peripheral nerve damage, the researchers looked at mouse models of Charcot Marie Tooth disease (CMT), a type of hereditary neuropathy.

"Going into this project, I thought that when you have a genetic nerve degeneration disorder, cells are dying and recovery isn't possible," says first author Lydia Daboussi, a former postdoctoral researcher in Pfaff's lab and current assistant professor at UC Los Angeles. "But our findings show that there are gene programs turned on by Mitf that repair some of the damage done in those chronic disease scenarios, and when you turn those programs off, disease symptoms get worse."

In mice with CMT, the researchers noticed that the Schwann cells completing the repairs had high levels of Mitf in their nucleiwhere the genetic instructions for how to be a Schwann cell and how to conduct repairs are stored.

Upon investigation of this relationship between Mitf and Schwann cells, they found that Mitf was in the cytoplasm of Schwann cells until sensing neuronal damage. Damage then prompted Mitf to relocate from the cytoplasm of the cell to the nucleus, where it would direct the Schwann cell to make repairs.

To validate the importance of Mitf in creating repair Schwann cells, the researchers removed Mitf altogether. In cases of both trauma and CMT, nerve repair was arrested in the absence of Mitfdemonstrating that Mitf is required for peripheral nerve repair and regeneration.

According to Daboussi, Mitf acts like a fire extinguisher. Always there, sitting in the Schwann cell, unnoticed until damage occurs. And when that damage occurs, Mitf is ready to go and immediately turns on the cell's repair functions.

Most surprising, noted Pfaff, was that Mitf was orchestrating these repairs during a chronic disease like CMT.

"Harnessing Schwann cell repair programs has great potential in treating chronic diseases," says Pfaff, also the Benjamin H. Lewis Chair at Salk. "It's possible that with targeted therapeutics, we can prompt more Schwann cells to repair peripheral nerve damage and push those repairs to completion in chronic cases. Furthermore, now that we have a better grasp on the repair mechanisms, we can see if it's possible to initiate repairs in the brain stem and spinal cord, too."

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalHC to hear plea against Robert Vadra on May 2 over remarks on Pahalgam massacre

InternationalSecretary Rubio talks to EAM Jaishankar, reaffirms US commitment against terrorism

InternationalUN chief renews call for immediate cessation of hostilities in Sudan

InternationalPower outage in Dutch city leaves over 20,000 households in dark

InternationalJordan hands down 20-year sentences in national security case

Technology Realted Stories

Technology‘WAVES 2025’ brings spotlight on India’s vibrant media and entertainment sector

TechnologyApple logs highest-ever shipment volume in India at 29 pc growth in March quarter

Technology75 pc of Indian businesses localise data as AI becomes core to strategy: Report

TechnologyPunjab starts first-of-its-kind B.Tech programme

TechnologyDynamic curriculum, continuous evolution of training modules key to stay relevant: Jitendra Singh